Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayode Ogungbenro

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
The Lancet. Rheumatology|August 25, 2020
Anakinra in COVID-19: important considerations for clinical trialsAndrew King, Andy Vail, Claire O'Leary, et al.
The Journal of Allergy and Clinical Immunology|July 23, 2016
Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunctionImran Satia, Nikolaos Tsamandouras, Kimberley Holt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 15, 2010
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Journal of Critical Care|April 7, 2017
The effect of veno-venous ECMO on the pharmacokinetics of Ritonavir, Darunavir, Tenofovir and LamivudineMohamed A Ghazi Suliman, Kayode Ogungbenro, Christos Kosmidis, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
British Journal of Clinical Pharmacology|June 23, 2011
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsSteven Lane, Sameh Al-Zubiedi, Ellen Hatch, et al.
Pharmaceutics|March 29, 2023
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in RatsNicola Melillo, Daniel Scotcher, J Gerry Kenna, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
British Journal of Clinical Pharmacology|January 15, 2026
Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemiaAndrew M Brandon, Hinke Huisman-Siebinga, Shelby Barnett, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
The Lancet. Rheumatology|August 25, 2020
Anakinra in COVID-19: important considerations for clinical trialsAndrew King, Andy Vail, Claire O'Leary, et al.
The Journal of Allergy and Clinical Immunology|July 23, 2016
Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunctionImran Satia, Nikolaos Tsamandouras, Kimberley Holt, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 15, 2010
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Journal of Critical Care|April 7, 2017
The effect of veno-venous ECMO on the pharmacokinetics of Ritonavir, Darunavir, Tenofovir and LamivudineMohamed A Ghazi Suliman, Kayode Ogungbenro, Christos Kosmidis, et al.
BMJ Open|September 24, 2020
Value of dynamic clinical and biomarker data for mortality risk prediction in COVID-19: a multicentre retrospective cohort studyCarlo Berzuini, Cathal Hannan, Andrew King, et al.
British Journal of Clinical Pharmacology|June 23, 2011
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsSteven Lane, Sameh Al-Zubiedi, Ellen Hatch, et al.
Pharmaceutics|March 29, 2023
Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug-Drug Interactions in RatsNicola Melillo, Daniel Scotcher, J Gerry Kenna, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Pharmaceutics|June 27, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid ArthritisStephanie F Ling, Kayode Ogungbenro, Adam S Darwich, et al.
British Journal of Clinical Pharmacology|January 15, 2026
Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemiaAndrew M Brandon, Hinke Huisman-Siebinga, Shelby Barnett, et al.
Pageof 10